Last10K.com

American Cryostem Corp (CRYO) SEC Filing 10-K Annual report for the fiscal year ending Sunday, September 30, 2012

American Cryostem Corp

CIK: 1468679 Ticker: CRYO
Document And Entity Information (USD $)
12 Months Ended
Sep. 30, 2012
Jan. 11, 2013
Mar. 31, 2012
Document and Entity Information [Abstract]      
Entity Registrant Name AMERICAN CRYOSTEM CORPORATION    
Document Type 10-K    
Current Fiscal Year End Date --09-30    
Entity Common Stock, Shares Outstanding   28,586,362  
Entity Public Float     $ 3,868,349
Amendment Flag false    
Entity Central Index Key 0001468679    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Smaller Reporting Company    
Entity Well-known Seasoned Issuer No    
Document Period End Date Sep. 30, 2012    
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus FY    

View differences made from one year to another to evaluate American Cryostem Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Cryostem Corp.

Continue

Assess how American Cryostem Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Balance Sheets
Balance Sheets (parentheticals)
Statement Of Cash Flows
Statement Of Changes In Shareholders Equity
Statements Of Operations
Accounting Policies, By Policy (policies)
Document And Entity Information
Note 1. Organization Of The Company And Significant Accounting Policies
Note 1. Organization Of The Company And Significant Accounting Policies (detail)
Note 1. Organization Of The Company And Significant Accounting Policies (tables)
Note 10. Fair Values Of Financial Instruments
Note 11. Reliance On Key Personnel
Note 12. Litigation
Note 13. Subsequent Events
Note 2. Going Concern
Note 2. Going Concern (detail)
Note 3. Loss Per Share
Note 3. Loss Per Share (detail)
Note 3. Loss Per Share (detail) - Summary Of Net Income (loss) Per Sharee
Note 3. Loss Per Share (tables)
Note 4. Property And Equipment
Note 4. Property And Equipment (detail)
Note 4. Property And Equipment (detail) - Summary Of Property And Equipment
Note 4. Property And Equipment (tables)
Note 5. Patent
Note 6. Note Payable
Note 6. Note Payable (detail)
Note 7. Income Taxes
Note 7. Income Taxes (detail) - Summary Of Income Taxes
Note 7. Income Taxes (tables)
Note 8. Commitments & Contingencies
Note 8. Commitments & Contingencies (detail)
Note 8. Commitments & Contingencies (detail) - Table Of Minimum Lease Payments Due On Capital Leases
Note 8. Commitments & Contingencies (tables)
Note 9. Common Stock Transactions
Note 9. Common Stock Transactions (detail)
Note 9. Common Stock Transactions (detail) - Table Of Common Stock Options Outstanding
Note 9. Common Stock Transactions (detail) - Table Of Fair Value Assumptions Of Options
Note 9. Common Stock Transactions (tables)

Material Contracts, Statements, Certifications & more

American Cryostem Corp provided additional information to their SEC Filing as exhibits

Ticker: CRYO
CIK: 1468679
Form Type: 10-K Annual Report
Accession Number: 0001019056-13-000045
Submitted to the SEC: Mon Jan 14 2013 5:19:44 PM EST
Accepted by the SEC: Mon Jan 14 2013
Period: Sunday, September 30, 2012
Industry: Health And Allied

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cryo/0001019056-13-000045.htm